Uncovering How to Target Glioblastoma Cancer Cells

November 30, 2022

Via: GEN

Researchers from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI) have been studying ways to uncover potential new drug therapies for the common and lethal brain cancer, glioblastoma. In a new study, the team discovered that […]

Why should pharma invest in digital products for those living with rare diseases?

November 23, 2022

Category: Industry, Pharma

Many will also face barriers to care, where access to specialists is limited and often geographically out of reach. That’s where technology coupled with user-centred design can help – bringing solutions and convenience to these pain points and positively impacting […]

Kids Born by C-Section May Have Weaker Response to Vaccines

November 16, 2022

Babies born via cesarean section may not mount as strong an immune response after some childhood vaccines compared to babies delivered vaginally, researchers suggest. Antibody levels can be checked in blood or saliva, and babies born vaginally had higher levels […]


Genomic testing ‘should be offered to all cancer patients in Scotland’

November 28, 2022

Via: Pharmaphorum

The Scottish Precision Medicines Industry Group (SPMIG) – set up by AstraZeneca, Lilly, Novartis and Roche – is calling on NHS Scotland to make genomic testing available for every cancer patient in the country, so they can receive drugs based […]

Industry, Pharma

How automation can help to address supply chain challenges in pharma

November 28, 2022

Via: Pharmaphorum

Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceutical companies can ensure drug production runs smoothly – even under stress. Modular set ups, remote monitoring systems, and automated batch processing can all assist in […]

Clinical Trials, Research and Development

MHRA, NHS England make available new prostate cancer treatment

November 28, 2022

Via: Pharmaphorum

There are over 52,000 cases of prostate cancer each year in the UK alone, with over 15,000 new cases of metastatic prostate cancer confirmed annually. The approval comes after the presentation of data from the ARASENS phase 3 clinical trial […]

Cell and Gene Therapy, Industry

Mainstreaming cell and gene therapy – Realizing its potential

November 28, 2022

Via: Biopharma Dive

Brief overview of the CGT landscape A useful starting point is to understand the different types of CGTs. The following are the definition of the three types: Cell therapies: involves the transfer of intact, live cells into a patient to […]


FogPharma clears another big-ticket financing for its ‘miniprotein’ pipeline

November 22, 2022

Via: Pharmaphorum

The Series D comes a little over 18 months after the six-year-old biotech’s third-round financing netted it around $107 million, taking its total raised to date north of $360 million. Ut comes just as FogPharma is preparing to start clinical […]